We further found that β-catenin was co-localized with RhoA in WPMY-1 and BPH-1 cells, and RhoA enhanced the stability of β-catenin protein, reduced the proteasome pathway degradation of β-catenin, as well as promoted its nuclear translocation. This evidence concerns the gene RHOA and benign prostatic hyperplasia.